Clinical Tips for Practitioners During Consultation Observe the patient before questioning posture, eye contact, gestures, facial expression, hygiene, and speech pattern reveal valuable clues
At 72 weeks, Tirzepatide users achieved an average weight reduction of 20.2% (absolute loss of 22.8 kg or 50.3 lbs) compared to 13.7% (15.0 kg or 33.1 lbs) with semaglutide
By doing this, your body can use the food you eat more efficiently, allowing you to lose weight more quickly and easily
however, there was no significant reduction in the risk of ischemic stroke
FDA approval criteria (what your provider can prescribe): Type 2 diabetes, any BMI BMI 30+ for weight management BMI 27+ with weight-related comorbidity for weight management Typical commercial insurance coverage criteria (what insurers will pay for): Type 2 diabetes with A1C 7.0% or higher despite metformin therapy BMI 30+ (some plans require BMI 35+) Documented failure of at least one 3-month lifestyle intervention program No history of medullary thyroid carcinoma or MEN2 syndrome Pre-authorization approval from medical director The gap between FDA approval and insurance coverage creates a large population of medically eligible patients who can't access brand-name Mounjaro due to cost
The American journal of clinical nutrition , 101 (2), 287-293
